Tevogen Bio Holdings Inc. Common Stock
Symbol: TVGN (NASDAQ)
0.67
▲ (0.01%) 0.000
Company Description:
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Key Stats
- Today's Open: $0.673
- Today's High: $0.675
- Today's Low: $0.663
- Today's Volume: 11.35K
- Yesterday Close: $0.6739
- Yesterday High: $0.6998
- Yesterday Low: $0.67
- Yesterday Volume: 297.86K
- Last Min Volume: 2
- Last Min High: $0.674
- Last Min Low: $0.674
- Last Min VWAP: $0.674
Company Profile
- Name: Tevogen Bio Holdings Inc. Common Stock
- Website: https://www.tevogen.com
- Listed Date: 2024-02-15
- Location: WARREN, NJ
- Market Status: Active
- CIK Number: 0001860871
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $137.95M
- Round Lot: 100
- Outstanding Shares: 196.71M
- Asset Type: CS
RECENT FILINGS FOR TVGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | 424B3 | View |
| 2025-09-26 | 8-K | View |
| 2025-08-18 | 4 | View |
| 2025-08-14 | 424B3 | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-25 | SCHEDULE 13D/A | View |
| 2025-07-10 | 424B3 | View |
| 2025-07-10 | 8-K | View |
| 2025-07-03 | 8-K | View |
| 2025-07-03 | 424B5 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-27 | 424B3 | View |
| 2025-06-26 | EFFECT | View |
| 2025-06-24 | CORRESP | View |
| 2025-06-24 | UPLOAD | View |
| 2025-06-23 | 424B3 | View |
Latest News on TVGN